IMPAX Names Arthur A. Koch, Jr. Senior Vice President, Finance, and Chief Financial Officer
Download this Press Release()
HAYWARD, Calif.--(BUSINESS WIRE)--April 1, 2005--IMPAX Laboratories, Inc. (NASDAQ:IPXL) today announced the appointment of Arthur A. Koch, Jr. as Senior Vice President, Finance, and Chief Financial Officer, effective immediately, reporting to the Chief Executive Officer.
has 30 years of finance, operations and public accounting experience, including service as Chief Financial Officer of three publicly traded healthcare companies
For the past seven years of his career, Mr. Koch has been with Strategic Diagnostics Inc. (NASDAQ:SDIX), a company that develops, manufactures and markets immunoassay-based diagnostic test kits, including six years as Chief Operating Officer, five months as interim Chief Executive Officer and five years as Chief Financial Officer and Vice President.
At Strategic Diagnostics
most recent responsibilities included responsibility for all P&L activities and leadership of the research, manufacturing and financial functions.
also was involved in several acquisitions and developed the company's investor relations campaign.
has held further CFO positions at Paracelsian Inc., IBAH Inc., Liberty Fish Company and Premier Solutions Ltd.
In addition, he has served as a corporate finance and operations consultant for numerous private companies, and spent the first eight years of his career at KPMG LLP, rising to the rank of senior manager.
Mr. Koch holds a Bachelor of Business Administration from Temple University and has been a Certified Public Accountant since 1977.